All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...

An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was ...

Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

The Trump administration said it was terminating mRNA vaccine research and shifting focus to other approaches, including a ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...

All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...

Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...

The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...

Teams that bring a variety of experience and expertise can spot problems faster and arrive at more well-rounded, viable ...

Health Canada approves Moderna’s updated Covid-19 mRNA vaccine, Spikevax, targeting SARS-CoV-2 variant LP.8.1 ...